In recent years, the fertility crisis has emerged as a silent yet significant challenge to modern society. While environmental issues like global warming command public attention, few are talking about what might be an even bigger threat: declining birth rates. Elon Musk has boldly warned that “population collapse due to low birth rates is a much bigger risk to civilization than global warming.” Yet the world remains largely unprepared for the long-term consequences.
The reasons for declining fertility rates are multifaceted, ranging from delayed family planning to hormone imbalances, the prevalence of microplastics, and even lifestyle choices. The simple reality is that couples today are waiting longer to have children, often missing the optimal fertility window. At age 30, for example, a woman has about a 20% chance of conception each month, while by age 35, that chance drops to 15%, and by 40, it plummets to just 5%. These statistics are staggering, especially as more couples find themselves seeking help when nature doesn’t cooperate.
A Global Issue With Far-Reaching Consequences
The global implications of declining fertility rates cannot be overstated. Entire nations—across five continents—are now reporting fertility rates below the replacement level required to sustain their populations. South Korea and Italy, for instance, have some of the lowest birth rates in the world. These nations are now facing the potential ethnocide and loss of their social systems as populations shrink rapidly.
A shrinking population also poses significant economic threats. Economies and government systems built on taxation and the labor of younger generations face collapse. Capital markets, supply chains, and even pension systems are at risk if the trend continues unchecked. With fewer young people to support aging populations, the social contract that many societies are built upon could crumble within the next one to two generations.
It is promising that governments are starting to pay attention to this crisis. In May, this year, South Korean President Yoon Suk Yeol, announced that the birth rate has become a national emergency and the country will mobilize its resource to establish the Ministry of Low Birth Rate Counter-Planning. Similarly, Robert Kennedy Jr. has made public statements on X, that he and Donald Trump intend to also investigate the decline in fertility rates and evaluate the causes.
A New Frontier in Assisted Reproductive Technology
In response to this crisis, companies like Gattaca Genomics are emerging at the forefront of the fight to reverse these troubling trends. By combining cutting-edge technology, artificial intelligence, and a global data ecosystem, Gattaca is redefining the landscape of Assisted Reproductive Technology (ART). Through advanced genetic testing services and time-lapse imaging of embryos, Gattaca aims to improve the efficiency and success rates of in vitro fertilization (IVF).
IVF has already become a widely accepted practice, with no signs of slowing down. Since 2019, it has grown by 10-15% each year, with 2.5% of all births in the U.S. now the result of ART. Gattaca is helping to streamline this process, making it more accessible to couples by working with IVF clinics worldwide, offering better embryo evaluation, and driving down costs through data efficiency.
The Need for Action on Multiple Fronts
Addressing the fertility crisis requires more than just technology. We need a comprehensive, global conversation. Economic incentives, government policies, healthcare education, and cultural shifts must all work in tandem to reverse the current trajectory. Governments can play an essential role by incentivizing earlier family planning and improving access to fertility treatments. Education about fertility, reproductive health, and the risks of delayed parenthood should be more widespread.
For women, time is not a luxury. Every year that passes reduces the window of opportunity to conceive naturally. And while ART provides a beacon of hope, it is not a guaranteed solution, nor is it always affordable. The physical, emotional, and financial toll that women endure in pursuit of having a child can be overwhelming. Gattaca Genomics recognizes this challenge and is committed to relieving some of these burdens through innovation, compassion, and cost reduction.
A Call to Action
As we stand on the cusp of a population decline that could reshape our civilization, we must take decisive action. Gattaca’s mission is not just to help couples have children—it is to lead the way in solving the population decline crisis. By focusing on patient care, collaborating with embryologists, and ensuring that ART is accessible and efficient, Gattaca is working to safeguard the future of families—and by extension, the future of society itself.
The time to act is now. We cannot afford to wait until the consequences of the fertility decline are staring us in the face. The conversation about fertility and family planning must shift to a national and global priority. If we address the problem head-on, we can ensure that future generations have the opportunity to thrive in a world where the dream of parenthood is not out of reach for anyone.
Egg donation and egg freezing are services that are available to women right now. A significant percentage of IVF pregnancies today rely on donor eggs. Women in their 20’s and 30’s are often focused on their education and career before they decide to start a family. It is important that if family planning is delayed, even just a few years, then egg freezing needs to be a part of women’s healthcare conversation. Egg banking services offer women the opportunity to plan early to freeze their eggs, so they have the opportunity to have children at a later stage in life.
Image: ID 186176165 © Noipornpan | Dreamstime.com

Michael Carbonara
Michael Carbonara is the Co-founder and CEO of Gattaca Genomics. Michael has lead innovations and technological advancements in the fertility, fintech, and energy sectors. Under his leadership Gattaca Genomics has solidified its position in the fertility industry, bringing innovation to help families and communities in need.
About Gattaca Genomics
Gattaca Genomics is data research and diagnostics company that leverages neural networks, and applies breakthrough technologies and artificial intelligence to enhance evaluations of fertility procedures and Assisted Reproductive Technology. Through serving medical professionals and patients globally with best-in-class innovations and industry leadership, Gattaca Genomics is setting the future standard for fertility care.
Discover more at https://gattacagenomics.com/